|
Volumn 380, Issue 6571, 1996, Pages 252-255
|
Functional recovery in parkinsonian monkeys treated with GDNF
a a a a a a b b b b c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
DOPAMINE;
NEUROTROPHIC FACTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BRADYKINESIA;
CONTROLLED STUDY;
CORPUS STRIATUM;
DOPAMINERGIC NERVE CELL;
GLIA CELL;
GLOBUS PALLIDUS;
INTRACEREBRAL DRUG ADMINISTRATION;
MESENCEPHALON;
NONHUMAN;
PARKINSON DISEASE;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RHESUS MONKEY;
SYMPTOMATOLOGY;
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE;
ANIMALS;
DOPAMINE;
FEMALE;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
MACACA MULATTA;
MESENCEPHALON;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURONS;
PARKINSON DISEASE;
RECOMBINANT PROTEINS;
|
EID: 13344277993
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/380252a0 Document Type: Article |
Times cited : (896)
|
References (22)
|